Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Assessment of CSF1R-Related Leukoencephalopathy Following Stem Cell Transplantation

NCT04503213 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04503213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04503213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Assessment of CSF1R-Related Leukoencephalopathy Following Stem Cell Transplantation
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Enrolling by invitation
Start date
July 21, 2020
Completion date
December 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alsp, csf1r-related leukoencephalopathy, hematopoietic stem cell transplantation, pold